Heart failure and angiotensin-converting enzyme inhibitors. Is there a need for specialty care?

Editorial

M A Scheiner et al. J Gen Intern Med. 1997 Sep.

. 1997 Sep;12(9):581-2.

doi: 10.1046/j.1525-1497.1997.07147.x.

No abstract available

Comment on

Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure.
Chin MH, Friedmann PD, Cassel CK, Lang RM. Chin MH, et al. J Gen Intern Med. 1997 Sep;12(9):523-30. doi: 10.1046/j.1525-1497.1997.07105.x. J Gen Intern Med. 1997. PMID: 9294785 Free PMC article.
Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics.
Chin MH, Wang JC, Zhang JX, Lang RM. Chin MH, et al. J Gen Intern Med. 1997 Sep;12(9):563-6. doi: 10.1046/j.1525-1497.1997.07110.x. J Gen Intern Med. 1997. PMID: 9294790 Free PMC article.

1. American College of Cardiology/American Heart Association Task Force on Practice Guidelines Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–98. - PubMed
1. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293–302. - PubMed
1. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:686–91. - PubMed
1. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669–77. - PubMed
1. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD) South Med J. 1995;88:514–23. - PubMed